Canada Markets close in 2 hrs 33 mins
  • S&P/TSX

    20,401.49
    +157.20 (+0.78%)
     
  • S&P 500

    4,395.64
    +41.45 (+0.95%)
     
  • DOW

    34,258.32
    +338.48 (+1.00%)
     
  • CAD/USD

    0.7831
    +0.0027 (+0.3438%)
     
  • BTC-CAD

    54,423.85
    -528.07 (-0.96%)
     
  • CMC Crypto 200

    1,089.55
    +49.07 (+4.72%)
     
  • GOLD FUTURES

    1,768.40
    -9.80 (-0.55%)
     
  • RUSSELL 2000

    2,218.56
    +32.38 (+1.48%)
     
  • 10-Yr Bond

    1.3360
    +0.0120 (+0.91%)
     
  • NASDAQ

    14,896.85
    +150.45 (+1.02%)
     
  • VOLATILITY

    20.87
    -3.49 (-14.33%)
     
  • FTSE

    7,083.37
    +102.39 (+1.47%)
     
  • NIKKEI 225

    29,639.40
    -200.31 (-0.67%)
     
  • CAD/EUR

    0.6693
    +0.0042 (+0.63%)
     

GBLT Receives €4.4m Thermometer Order from One of the Largest Global Retailers

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

TORONTO and DUEREN, Germany, July 29, 2021 /CNW/ - GBLT Corp. (TSXV: GBLT) (OTCQB: GBLTF) (FSE: 4G9) ("GBLT" or the "Company") is pleased to announce that it has received an order for its proprietary Dr. Senst branded thermometers from one of the world's largest retailers, amounting to €4.4m. The order is deliverable in the first half of 2022 and represents continued market penetration of the Company's growing Dr. Senst branded healthcare solutions in Germany, Italy, France and Poland.

The global thermometer market totaled USD $1.2B in 2020 and is expected to exceed USD $2.3B by 2028, primarily driven by increase in the prevalence of infectious diseases, and other medical conditions, such as malaria, and increasing health consciousness and rising patient awareness.1 As one of Europe's fastest growing brands, GBLT continues to capture a significant portion of this market as more and more consumers recognize the high-quality products offered under the Dr. Senst brand, while also continuing to expand its presence in retailers globally.

"We continue to see growing demand for our Dr. Senst branded solutions, and today's announcement represents a 20% increase over what we will deliver in 2021 in thermometer orders alone, highlighting the strong demand from our retailer partners and more importantly their customers," said Dr. Thilo Senst, Founder and CEO of GBLT Corp. "Our clients have clearly expressed to us that while COVID-19 is here to stay for the foreseeable future, the nature of personal healthcare products has also changed, and they are planning to meet this new demand long after the pandemic is over. The Dr. Senst brand has grown tremendously over the past 18 months as consumers are now more conscious of protecting themselves from even the common cold."

About GBLT:

GBLT Corp., through its operating company, GBT GmbH, designs, manufactures and supplies mobile storage, battery and personal protection equipment to some of the largest retail chains across the globe. GBT is also an official licensee for Kodak mobile storage systems and AGFAPHOTO mobile energy products. The Company's personal protection equipment is primarily sold throughout Europe under Dr. Senst brand, which is owned and operated by GBT GmbH.

For more information, please visit www.gbt-international.com and www.gbltcorp.com.

Forward-Looking Information

Certain statements in this news release, which are not historical in nature, constitute "forward looking statements" within the meaning of that phrase under applicable Canadian securities law. These statements include, but are not limited to, statements or information concerning the Company's proposed activities under the Agreement, the Company's ability to achieve sales, commercial or otherwise, from its products, and the expectations of the Company regarding funding payments due pursuant to the Agreement. These statements reflect management's current assumptions and expectations and by their nature are subject to certain underlying assumptions, known and unknown risks and uncertainties and other factors which may cause actual results, performance or events to be materially different from those expressed or implied by such forward looking statements. Except as required pursuant to applicable securities laws, the Company will not update these forward-looking statements to reflect events or circumstances after the date hereof. More detailed information about potential factors that could affect financial results is included in the documents filed from time to time with the Canadian securities regulatory authorities by the Company. Readers are cautioned not to place undue reliance on forward looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider
(as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE GBLT Corp.

Cision
Cision

View original content: http://www.newswire.ca/en/releases/archive/July2021/29/c1548.html

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting